Sensitivity of amyloid formation by human islet amyloid polypeptide to mutations at residue 20

Ping Cao, Ling Hsien Tu, Andisheh Abedini, Olesya Levsh, Rehana Akter, Vadim Patsalo, Ann Marie Schmidt, Daniel P. Raleigh

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Islet amyloid polypeptide (IAPP, amylin) is responsible for amyloid formation in type 2 diabetes and in islet cell transplants. The only known natural mutation found in mature human IAPP is a Ser20-to-Gly missense mutation, found with small frequency in Chinese and Japanese populations. The mutation appears to be associated with increased risk of early-onset type 2 diabetes. Early measurements in the presence of organic co-solvents showed that S20G-IAPP formed amyloid more quickly than the wild type. We confirm that the mutant accelerates amyloid formation under a range of conditions including in the absence of co-solvents. Ser20 adopts a normal backbone geometry, and the side chain makes no steric clashes in models of IAPP amyloid fibers, suggesting that the increased rate of amyloid formation by the mutant does not result from the relief of steric incompatibility in the fiber state. Transmission electronic microscopy, circular dichroism, and seeding studies were used to probe the structure of the resulting fibers. The S20G-IAPP peptide is toxic to cultured rat INS-1 (transformed rat insulinoma-1) β-cells. The sensitivity of amyloid formation to the identity of residue 20 was exploited to design a variant that is much slower to aggregate and that inhibits amyloid formation by wild-type IAPP. An S20K mutant forms amyloid with an 18-fold longer lag phase in homogeneous solution. Thioflavin T binding assays, together with experiments using a p-cyanophenylalanine (p-cyanoPhe) variant of human IAPP, show that the designed S20K mutant inhibits amyloid formation by human IAPP. The experiments illustrate how p-cyanoPhe can be exploited to monitor amyloid formation even in the presence of other amyloidogenic proteins.

Original languageEnglish
Pages (from-to)282-295
Number of pages14
JournalJournal of Molecular Biology
Volume421
Issue number2-3
DOIs
Publication statusPublished - 2012 Aug 10

Fingerprint

Islet Amyloid Polypeptide
Amyloid
Mutation
Type 2 Diabetes Mellitus
Amyloidogenic Proteins
Insulinoma
Poisons
Missense Mutation
Circular Dichroism
Islets of Langerhans
Microscopy

Keywords

  • amylin
  • amyloid-inhibitor
  • islet amyloid polypeptide
  • missense mutation
  • type 2 diabetes

ASJC Scopus subject areas

  • Structural Biology
  • Molecular Biology

Cite this

Sensitivity of amyloid formation by human islet amyloid polypeptide to mutations at residue 20. / Cao, Ping; Tu, Ling Hsien; Abedini, Andisheh; Levsh, Olesya; Akter, Rehana; Patsalo, Vadim; Schmidt, Ann Marie; Raleigh, Daniel P.

In: Journal of Molecular Biology, Vol. 421, No. 2-3, 10.08.2012, p. 282-295.

Research output: Contribution to journalArticle

Cao, P, Tu, LH, Abedini, A, Levsh, O, Akter, R, Patsalo, V, Schmidt, AM & Raleigh, DP 2012, 'Sensitivity of amyloid formation by human islet amyloid polypeptide to mutations at residue 20', Journal of Molecular Biology, vol. 421, no. 2-3, pp. 282-295. https://doi.org/10.1016/j.jmb.2011.12.032
Cao, Ping ; Tu, Ling Hsien ; Abedini, Andisheh ; Levsh, Olesya ; Akter, Rehana ; Patsalo, Vadim ; Schmidt, Ann Marie ; Raleigh, Daniel P. / Sensitivity of amyloid formation by human islet amyloid polypeptide to mutations at residue 20. In: Journal of Molecular Biology. 2012 ; Vol. 421, No. 2-3. pp. 282-295.
@article{acae6193153c43dc815f8f93057ad14d,
title = "Sensitivity of amyloid formation by human islet amyloid polypeptide to mutations at residue 20",
abstract = "Islet amyloid polypeptide (IAPP, amylin) is responsible for amyloid formation in type 2 diabetes and in islet cell transplants. The only known natural mutation found in mature human IAPP is a Ser20-to-Gly missense mutation, found with small frequency in Chinese and Japanese populations. The mutation appears to be associated with increased risk of early-onset type 2 diabetes. Early measurements in the presence of organic co-solvents showed that S20G-IAPP formed amyloid more quickly than the wild type. We confirm that the mutant accelerates amyloid formation under a range of conditions including in the absence of co-solvents. Ser20 adopts a normal backbone geometry, and the side chain makes no steric clashes in models of IAPP amyloid fibers, suggesting that the increased rate of amyloid formation by the mutant does not result from the relief of steric incompatibility in the fiber state. Transmission electronic microscopy, circular dichroism, and seeding studies were used to probe the structure of the resulting fibers. The S20G-IAPP peptide is toxic to cultured rat INS-1 (transformed rat insulinoma-1) β-cells. The sensitivity of amyloid formation to the identity of residue 20 was exploited to design a variant that is much slower to aggregate and that inhibits amyloid formation by wild-type IAPP. An S20K mutant forms amyloid with an 18-fold longer lag phase in homogeneous solution. Thioflavin T binding assays, together with experiments using a p-cyanophenylalanine (p-cyanoPhe) variant of human IAPP, show that the designed S20K mutant inhibits amyloid formation by human IAPP. The experiments illustrate how p-cyanoPhe can be exploited to monitor amyloid formation even in the presence of other amyloidogenic proteins.",
keywords = "amylin, amyloid-inhibitor, islet amyloid polypeptide, missense mutation, type 2 diabetes",
author = "Ping Cao and Tu, {Ling Hsien} and Andisheh Abedini and Olesya Levsh and Rehana Akter and Vadim Patsalo and Schmidt, {Ann Marie} and Raleigh, {Daniel P.}",
year = "2012",
month = "8",
day = "10",
doi = "10.1016/j.jmb.2011.12.032",
language = "English",
volume = "421",
pages = "282--295",
journal = "Journal of Molecular Biology",
issn = "0022-2836",
publisher = "Academic Press Inc.",
number = "2-3",

}

TY - JOUR

T1 - Sensitivity of amyloid formation by human islet amyloid polypeptide to mutations at residue 20

AU - Cao, Ping

AU - Tu, Ling Hsien

AU - Abedini, Andisheh

AU - Levsh, Olesya

AU - Akter, Rehana

AU - Patsalo, Vadim

AU - Schmidt, Ann Marie

AU - Raleigh, Daniel P.

PY - 2012/8/10

Y1 - 2012/8/10

N2 - Islet amyloid polypeptide (IAPP, amylin) is responsible for amyloid formation in type 2 diabetes and in islet cell transplants. The only known natural mutation found in mature human IAPP is a Ser20-to-Gly missense mutation, found with small frequency in Chinese and Japanese populations. The mutation appears to be associated with increased risk of early-onset type 2 diabetes. Early measurements in the presence of organic co-solvents showed that S20G-IAPP formed amyloid more quickly than the wild type. We confirm that the mutant accelerates amyloid formation under a range of conditions including in the absence of co-solvents. Ser20 adopts a normal backbone geometry, and the side chain makes no steric clashes in models of IAPP amyloid fibers, suggesting that the increased rate of amyloid formation by the mutant does not result from the relief of steric incompatibility in the fiber state. Transmission electronic microscopy, circular dichroism, and seeding studies were used to probe the structure of the resulting fibers. The S20G-IAPP peptide is toxic to cultured rat INS-1 (transformed rat insulinoma-1) β-cells. The sensitivity of amyloid formation to the identity of residue 20 was exploited to design a variant that is much slower to aggregate and that inhibits amyloid formation by wild-type IAPP. An S20K mutant forms amyloid with an 18-fold longer lag phase in homogeneous solution. Thioflavin T binding assays, together with experiments using a p-cyanophenylalanine (p-cyanoPhe) variant of human IAPP, show that the designed S20K mutant inhibits amyloid formation by human IAPP. The experiments illustrate how p-cyanoPhe can be exploited to monitor amyloid formation even in the presence of other amyloidogenic proteins.

AB - Islet amyloid polypeptide (IAPP, amylin) is responsible for amyloid formation in type 2 diabetes and in islet cell transplants. The only known natural mutation found in mature human IAPP is a Ser20-to-Gly missense mutation, found with small frequency in Chinese and Japanese populations. The mutation appears to be associated with increased risk of early-onset type 2 diabetes. Early measurements in the presence of organic co-solvents showed that S20G-IAPP formed amyloid more quickly than the wild type. We confirm that the mutant accelerates amyloid formation under a range of conditions including in the absence of co-solvents. Ser20 adopts a normal backbone geometry, and the side chain makes no steric clashes in models of IAPP amyloid fibers, suggesting that the increased rate of amyloid formation by the mutant does not result from the relief of steric incompatibility in the fiber state. Transmission electronic microscopy, circular dichroism, and seeding studies were used to probe the structure of the resulting fibers. The S20G-IAPP peptide is toxic to cultured rat INS-1 (transformed rat insulinoma-1) β-cells. The sensitivity of amyloid formation to the identity of residue 20 was exploited to design a variant that is much slower to aggregate and that inhibits amyloid formation by wild-type IAPP. An S20K mutant forms amyloid with an 18-fold longer lag phase in homogeneous solution. Thioflavin T binding assays, together with experiments using a p-cyanophenylalanine (p-cyanoPhe) variant of human IAPP, show that the designed S20K mutant inhibits amyloid formation by human IAPP. The experiments illustrate how p-cyanoPhe can be exploited to monitor amyloid formation even in the presence of other amyloidogenic proteins.

KW - amylin

KW - amyloid-inhibitor

KW - islet amyloid polypeptide

KW - missense mutation

KW - type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84862277598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862277598&partnerID=8YFLogxK

U2 - 10.1016/j.jmb.2011.12.032

DO - 10.1016/j.jmb.2011.12.032

M3 - Article

C2 - 22206987

AN - SCOPUS:84862277598

VL - 421

SP - 282

EP - 295

JO - Journal of Molecular Biology

JF - Journal of Molecular Biology

SN - 0022-2836

IS - 2-3

ER -